ISRCTN85066174
Completed
N/A
Botulinum Toxin in the management of spasticity in children with cerebral palsy: a randomised double blind trial
HS R&D Regional Programme Register - Department of Health (UK)0 sites0 target enrollmentJanuary 23, 2004
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cerebral palsy
- Sponsor
- HS R&D Regional Programme Register - Department of Health (UK)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children with spastic diplegia or hemiplegia
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
N/A
The Efficacy of Botulinum Toxin in Spastic Neuropathic BladderSpastic Neurogenic BladderNCT03407183AHMED FARAHAT HASSAN20
Recruiting
Phase 4
Efficacy of botulinum toxin in pediatric spasticity: a randomized trial comparing 2- to 4- sites hamstring injectioSpastic Cerebral palsyCerebral palsyMuscle SpasticityBotulinum ToxinsTCTR20150803003Thammasat University80
Completed
N/A
Efficiency of Botulinum Toxin Injection for Spastic Equinovarus Foot in Post Stroke Hemiparetic PatientsSpastic Equinovarus FootNCT03405948Assistance Publique Hopitaux De Marseille84
Completed
Phase 4
Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gaitHereditary Spastic Paraparesishereditary spasticity of the lower limbs1002929910041543NL-OMON32926niversitair Medisch Centrum Sint Radboud20
Active, Not Recruiting
Phase 1
Botulinum toxin for treating calf muscle spasticity in Hereditary Spastic Paraparesis (HSP): functional effects on dynamic balance and gait - FEBOCHSubjects with hereditary spastic paraparesis (HSP)MedDRA version: 9.1Level: LLTClassification code 10019903Term: Hereditary spastic paraplegiaEUCTR2009-012073-34-NLRadboud University Nijmegen Medical Centre20